David Joseph
Edith Cowan University(AU)The University of Western Australia(AU)Queensland Government(AU)Sir Charles Gairdner Hospital(AU)University of Alabama at Birmingham(US)Max Planck Institute for the Study of Religious and Ethnic Diversity(DE)Pediatric Nephrology of Alabama(US)James H. Quillen VA Medical Center(US)Max Planck Institute for Multidisciplinary SciencesClaremont Colleges(US)
Publications by Year
Research Areas
Cancer survivorship and care, Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Breast Cancer Treatment Studies, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Surgery alone versus chemoradiotherapy followed by surgery for resectable cancer of the oesophagus: a randomised controlled phase III trial(2005)929 cited
- → Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer(2000)557 cited
- → Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma(2020)294 cited
- CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer.(2003)
- → Treatment of Coronavirus Disease 2019 Patients with Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality(2020)249 cited
- → Safety and efficacy of resistance exercise in prostate cancer patients with bone metastases(2013)234 cited
- P53 alteration and microsatellite instability have predictive value for survival benefit from chemotherapy in stage III colorectal carcinoma.